NCT00626626: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation |
|
|
| Terminated | 1/2 | 8 | US | Clofar, Cyclophos, Alemtuzumab, CLOLAR, Clofar, Cyclophos,Alemtuzumab(Ph II), Clolar, Campath | Milton S. Hershey Medical Center | Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma | 01/10 | 01/10 | | |
